TCL Archive DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate October 1, 1976
TCL Archive In Brief: NCAB Still Without New Appinees As Carter, Califano Delay Drags On; Keele to U. Kansas January 19, 1979
TCL Archive In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial April 29, 1988
TCL Archive News Analysis by Keith Baggerly: Duke Trials Went On Despite FDA Statements January 27, 2012
